Seretide Diskus
Sponsors
GlaxoSmithKline, Hanmi Pharmaceutical Company Limited, Orion Corporation, Orion Pharma
Conditions
AsthmaPulmonary Disease, Chronic Obstructive
Phase 1
Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.
CompletedNCT01494610
Start: 2010-10-25End: 2011-06-08Updated: 2019-02-26
Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
CompletedNCT01521455
Start: 2012-02-29End: 2013-07-31Updated: 2013-08-23
A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol
CompletedNCT01540708
Start: 2012-01-16End: 2012-09-04Updated: 2018-06-19
Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus
CompletedNCT01766843
Start: 2013-01-31End: 2013-05-31Updated: 2014-01-03
Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus
CompletedNCT01856621
Start: 2013-05-31End: 2013-09-30Updated: 2014-01-03
Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus
CompletedNCT02162485
Start: 2014-06-30End: 2015-09-30Updated: 2015-09-29
Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus
CompletedNCT03060044
Start: 2016-07-31End: 2016-11-30Updated: 2017-03-03